The cost effectiveness of dextranomer and eusol in the treatment of infected surgical wounds.
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001458:Bandages; D001881:Borates; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003911:Dextrans / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D012973:Sodium Hypochlorite; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000191:economics / Q000628:therapy*
D000890:Anti-Infective Agents; D001881:Borates; D003911:Dextrans; C013471:dextranomer; C024611:Eusol; D012973:Sodium Hypochlorite